PL1689724T3 - Związki chinazolinonowe jako leki przeciwnowotworowe - Google Patents

Związki chinazolinonowe jako leki przeciwnowotworowe

Info

Publication number: PL1689724T3
Authority: PL; Poland
Prior art keywords: quinazolinone compounds; anticancer agents; quinazolinone; alone; compounds
Prior art date: 2003-11-25

Application number

PL04812051T

Other languages

English (en)

Inventor

Weibo Wang

Liana M Lagniton

Ryan N Constantine

Manoj C Desai

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-25

Filing date

2004-11-24

Publication date

2012-05-31

2004-11-24 Application filed by Novartis Ag filed Critical Novartis Ag

2012-05-31 Publication of PL1689724T3 publication Critical patent/PL1689724T3/pl

Links

AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 title abstract 4
239000002246 antineoplastic agent Substances 0.000 title 1
239000003814 drug Substances 0.000 abstract 2
229940124597 therapeutic agent Drugs 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL04812051T 2003-11-25 2004-11-24 Związki chinazolinonowe jako leki przeciwnowotworowe PL1689724T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US52505903P	2003-11-25	2003-11-25
EP04812051A EP1689724B1 (en)	2003-11-25	2004-11-24	Quinazolinone compounds as anticancer agents
PCT/US2004/039448 WO2005051922A1 (en)	2003-11-25	2004-11-24	Quinazolinone compounds as anticancer agents

Publications (1)

Publication Number	Publication Date
PL1689724T3 true PL1689724T3 (pl)	2012-05-31

Family

ID=34632957

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04812051T PL1689724T3 (pl)	2003-11-25	2004-11-24	Związki chinazolinonowe jako leki przeciwnowotworowe

Country Status (17)

Country	Link
US (2)	US7939539B2 (pl)
EP (1)	EP1689724B1 (pl)
JP (2)	JP4778439B2 (pl)
KR (1)	KR20060127413A (pl)
CN (1)	CN1886384A (pl)
AT (1)	ATE538103T1 (pl)
AU (1)	AU2004293464A1 (pl)
CA (1)	CA2546932A1 (pl)
CY (1)	CY1112478T1 (pl)
DK (1)	DK1689724T3 (pl)
ES (1)	ES2376552T3 (pl)
IL (1)	IL175714A0 (pl)
PL (1)	PL1689724T3 (pl)
PT (1)	PT1689724E (pl)
SG (1)	SG148202A1 (pl)
SI (1)	SI1689724T1 (pl)
WO (1)	WO2005051922A1 (pl)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545004B1 (en) *	1999-10-27	2003-04-08	Cytokinetics, Inc.	Methods and compositions utilizing quinazolinones
US7671200B2 (en) *	1999-10-27	2010-03-02	Cytokinetics, Inc.	Quinazolinone KSP inhibitors
US7230000B1 (en) *	1999-10-27	2007-06-12	Cytokinetics, Incorporated	Methods and compositions utilizing quinazolinones
WO2003070701A2 (en) *	2002-02-15	2003-08-28	Cytokinetics, Inc.	Syntheses of quinazolinones
US7214800B2 (en) *	2002-05-09	2007-05-08	Cytokinetics, Inc.	Compounds, compositions, and methods
EP1513820A4 (en)	2002-05-23	2006-09-13	Cytokinetics Inc	COMPOUNDS, COMPOSITIONS AND METHODS
AU2003256805A1 (en)	2002-07-23	2004-02-09	Cytokinetics, Inc.	Compounds compositions and methods
WO2004034972A2 (en) *	2002-09-30	2004-04-29	Cytokinetics, Inc.	Compounds, compositions, and methods
NZ551004A (en)	2004-04-02	2010-07-30	Prana Biotechnology Ltd	Neurologically-active compounds
CN101027309B (zh)	2004-08-18	2010-10-27	阿斯利康(瑞典)有限公司	所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途
EP1786265A4 (en) *	2004-08-30	2009-08-19	Smithkline Beecham Corp	NEW COMPOSITIONS AND PROCESSING METHODS
US20080064680A1 (en) *	2004-09-14	2008-03-13	Bamdad Cynthia C	Methods for Diagnosis and Treatment of Cancer
CA2669917A1 (en)	2006-11-17	2008-05-22	Dawn M. George	Aminopyrrolidines as chemokine receptor antagonists
KR100916160B1 (ko) *	2007-02-21	2009-09-08	(주)바이오버드	약제학적 항암 조성물
WO2009102537A1 (en) *	2008-02-14	2009-08-20	Merck & Co., Inc.	Inhibitors of checkpoint kinases
CN101250189B (zh) *	2008-03-25	2010-06-16	中山大学	双脂肪氨基取代喹唑酮衍生物及其制备方法与作为抗癌药物的应用
US8440693B2 (en)	2009-12-22	2013-05-14	Novartis Ag	Substituted isoquinolinones and quinazolinones
CN101857595B (zh) *	2010-05-21	2012-11-21	中山大学	一种喹唑酮衍生物及其制备方法和作为抗癌药物的用途
CN101899009B (zh) *	2010-07-30	2012-04-04	江苏昊华精细化工有限公司	医药中间体4(h)喹唑酮的制造方法
CN101967127B (zh) *	2010-09-28	2013-05-29	中山大学	一种喹唑啉衍生物及其制备方法和制备抗癌药物中的应用
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
EP2855483B1 (en)	2012-05-24	2017-10-25	Novartis AG	Pyrrolopyrrolidinone compounds
CN103012291B (zh) *	2012-12-17	2014-09-03	中山大学	一种2-苯基喹唑啉衍生物及其制备方法与在制备抗癌药物中的应用
NZ708864A (en)	2012-12-21	2016-09-30	Gilead Calistoga Llc	Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
JP6207100B2 (ja)	2012-12-21	2017-10-04	ギリアードカリストガエルエルシー	イソキノリノンまたはキナゾリノンホスファチジルイノシトール３−キナーゼ阻害剤
WO2014115080A1 (en)	2013-01-22	2014-07-31	Novartis Ag	Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
US9403827B2 (en)	2013-01-22	2016-08-02	Novartis Ag	Substituted purinone compounds
MX2015016344A (es)	2013-05-27	2016-03-01	Novartis Ag	Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
CA2912986A1 (en)	2013-05-28	2014-12-04	Novartis Ag	Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
US9714249B2 (en)	2013-05-28	2017-07-25	Novartis Ag	Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
ES2667173T3 (es)	2013-06-14	2018-05-09	Gilead Calistoga Llc	Inhibidores de fosfatidilinositol 3-quinasa
WO2015051241A1 (en)	2013-10-04	2015-04-09	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
MX2021012208A (es)	2013-10-04	2023-01-19	Infinity Pharmaceuticals Inc	Compuestos heterocíclicos y usos de los mismos.
US9550796B2 (en)	2013-11-21	2017-01-24	Novartis Ag	Pyrrolopyrrolone derivatives and their use as BET inhibitors
PL3086814T3 (pl)	2013-12-23	2020-12-28	Bayer Pharma Aktiengesellschaft	Koniugaty środka wiążącego (ADC) z inhibitorami KSP
NZ724368A (en)	2014-03-19	2023-07-28	Infinity Pharmaceuticals Inc	Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US10786578B2 (en)	2014-08-05	2020-09-29	Novartis Ag	CKIT antibody drug conjugates
WO2016054491A1 (en)	2014-10-03	2016-04-07	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
CN107635586B (zh)	2014-12-15	2021-09-24	拜耳医药股份有限公司	Ksp抑制剂与无糖基化抗-tweakr抗体的抗体-药物缀合物(adc)
RU2751512C2 (ru)	2015-06-22	2021-07-14	Байер Фарма Акциенгезельшафт	Конъюгаты антитела и лекарственного средства (adc) и конъюгаты антитела и пролекарства (apdc), содержащие ферментативно расщепляемые группы
US11071788B2 (en)	2015-06-23	2021-07-27	Bayer Pharma Aktiengesellschaft	Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
WO2016207094A1 (de)	2015-06-23	2016-12-29	Bayer Pharma Aktiengesellschaft	Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-tweakr-antikörpern
WO2017003723A1 (en)	2015-07-01	2017-01-05	Crinetics Pharmaceuticals, Inc.	Somatostatin modulators and uses thereof
EP4585268A3 (en)	2015-09-14	2025-10-15	Twelve Therapeutics, Inc.	Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
US10759806B2 (en)	2016-03-17	2020-09-01	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
WO2017214269A1 (en)	2016-06-08	2017-12-14	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
WO2017216028A1 (en)	2016-06-15	2017-12-21	Bayer Pharma Aktiengesellschaft	Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies
TW201813963A (zh)	2016-09-23	2018-04-16	美商基利科學股份有限公司	磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh)	2016-09-23	2018-07-16	美商基利科學股份有限公司	磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh)	2016-09-23	2018-05-01	美商基利科學股份有限公司	磷脂醯肌醇3-激酶抑制劑
JP7066714B2 (ja)	2016-12-21	2022-05-13	バイエル・ファルマ・アクティエンゲゼルシャフト	酵素的に切断可能な基を有する抗体薬物コンジュゲート（ａｄｃ）
JP7030811B2 (ja)	2016-12-21	2022-03-07	バイエル・ファルマ・アクティエンゲゼルシャフト	Ｋｓｐ阻害剤を有する特異的抗体－薬物コンジュゲート（ａｄｃ）
US11028068B2 (en)	2017-07-25	2021-06-08	Crinetics Pharmaceuticals, Inc.	Somatostatin modulators and uses thereof
JP2021527640A (ja)	2018-06-18	2021-10-14	バイエルアクチェンゲゼルシャフトＢａｙｅｒＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	酵素的に切断可能なリンカーおよび改善された活性プロファイルを有する、ｃｘｃｒ５に対して向けられるバインダー／活性薬剤複合体
CN111499634B (zh) *	2019-01-31	2023-05-12	贝达药业股份有限公司	一种喹唑啉化合物及其在医药上的应用
WO2021086038A1 (ko)	2019-10-31	2021-05-06	홀로스메딕 주식회사	신규한 화합물 및 이를 포함하는 암 예방 또는 치료용 약학 조성물
KR102682775B1 (ko)	2020-06-26	2024-07-08	홀로스메딕 주식회사	신규한 화합물의 제조방법
WO2022231377A1 (ko)	2021-04-29	2022-11-03	홀로스메딕 주식회사	신규한 화합물 및 이를 포함하는 암 예방 또는 치료용 약학 조성물 및 그의 용도
KR102862736B1 (ko) *	2022-12-07	2025-09-22	부산대학교 산학협력단	신규 2-((트랜스-4-(4-아릴옥시)사이클로헥실)아미노)퀴나졸리논 유도체 및 이의 제조방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4329418A1 (de) *	1993-09-01	1995-03-02	Agfa Gevaert Ag	Gelbkuppler
US6545004B1 (en) *	1999-10-27	2003-04-08	Cytokinetics, Inc.	Methods and compositions utilizing quinazolinones
ATE327224T1 (de) *	1999-10-27	2006-06-15	Cytokinetics Inc	Chinazolinone benutzende verfahren und zusammenstellungen
JP2002296741A (ja) *	2001-03-30	2002-10-09	Fuji Photo Film Co Ltd	色素形成カプラー、ハロゲン化銀写真感光材料およびアゾメチン色素化合物
US6677110B2 (en) *	2001-03-30	2004-01-13	Fuji Photo Film Co., Ltd.	Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
JP4267838B2 (ja) *	2001-03-30	2009-05-27	富士フイルム株式会社	色素形成カプラー、ハロゲン化銀写真感光材料およびアゾメチン色素化合物
JP2002318442A (ja) *	2001-04-20	2002-10-31	Fuji Photo Film Co Ltd	色素形成カプラー、ハロゲン化銀写真感光材料およびアゾメチン色素化合物
JP4267840B2 (ja) *	2001-04-20	2009-05-27	富士フイルム株式会社	色素形成カプラー、ハロゲン化銀写真感光材料およびアゾメチン色素化合物
CA2465491A1 (en)	2001-11-07	2003-05-15	Merck & Co., Inc.	Mitotic kinesin inhibitors
US7378411B2 (en) *	2001-12-06	2008-05-27	Merck & Co., Inc.	Substituted thienopyrimidinones as a mitotic kinesin inhibitor
US7214800B2 (en)	2002-05-09	2007-05-08	Cytokinetics, Inc.	Compounds, compositions, and methods
EP1513820A4 (en)	2002-05-23	2006-09-13	Cytokinetics Inc	COMPOUNDS, COMPOSITIONS AND METHODS
WO2004039774A2 (en)	2002-05-23	2004-05-13	Merck & Co., Inc.	Mitotic kinesin inhibitors
US20040048853A1 (en)	2002-08-21	2004-03-11	Gustave Bergnes	Compounds, compositions, and methods
WO2004034972A2 (en)	2002-09-30	2004-04-29	Cytokinetics, Inc.	Compounds, compositions, and methods

2004
- 2004-11-24 US US10/996,814 patent/US7939539B2/en not_active Expired - Fee Related
- 2004-11-24 CA CA002546932A patent/CA2546932A1/en not_active Abandoned
- 2004-11-24 AU AU2004293464A patent/AU2004293464A1/en not_active Abandoned
- 2004-11-24 SG SG200808730-6A patent/SG148202A1/en unknown
- 2004-11-24 SI SI200431833T patent/SI1689724T1/sl unknown
- 2004-11-24 PL PL04812051T patent/PL1689724T3/pl unknown
- 2004-11-24 CN CNA2004800348103A patent/CN1886384A/zh active Pending
- 2004-11-24 DK DK04812051.3T patent/DK1689724T3/da active
- 2004-11-24 JP JP2006541684A patent/JP4778439B2/ja not_active Expired - Fee Related
- 2004-11-24 ES ES04812051T patent/ES2376552T3/es not_active Expired - Lifetime
- 2004-11-24 WO PCT/US2004/039448 patent/WO2005051922A1/en not_active Ceased
- 2004-11-24 PT PT04812051T patent/PT1689724E/pt unknown
- 2004-11-24 AT AT04812051T patent/ATE538103T1/de active
- 2004-11-24 KR KR1020067012603A patent/KR20060127413A/ko not_active Withdrawn
- 2004-11-24 EP EP04812051A patent/EP1689724B1/en not_active Expired - Lifetime
2006
- 2006-05-17 IL IL175714A patent/IL175714A0/en unknown
2010
- 2010-12-21 JP JP2010285141A patent/JP2011084570A/ja not_active Withdrawn
2011
- 2011-04-12 US US13/085,048 patent/US20110190293A1/en not_active Abandoned
2012
- 2012-03-12 CY CY20121100255T patent/CY1112478T1/el unknown

Also Published As

Publication number	Publication date
PT1689724E (pt)	2012-02-06
JP2011084570A (ja)	2011-04-28
EP1689724A1 (en)	2006-08-16
ATE538103T1 (de)	2012-01-15
IL175714A0 (en)	2006-09-05
DK1689724T3 (da)	2012-02-27
WO2005051922A1 (en)	2005-06-09
US20050209254A1 (en)	2005-09-22
CA2546932A1 (en)	2005-06-09
JP4778439B2 (ja)	2011-09-21
CY1112478T1 (el)	2015-12-09
SI1689724T1 (sl)	2012-04-30
KR20060127413A (ko)	2006-12-12
US7939539B2 (en)	2011-05-10
US20110190293A1 (en)	2011-08-04
ES2376552T3 (es)	2012-03-14
AU2004293464A1 (en)	2005-06-09
EP1689724B1 (en)	2011-12-21
SG148202A1 (en)	2008-12-31
JP2007512368A (ja)	2007-05-17
CN1886384A (zh)	2006-12-27

Publication	Publication Date	Title
IL175714A0 (en)	2006-09-05	Quinazolinone compounds as anticancer agents
WO2005070930A3 (en)	2006-01-19	Tetrahydrocarboline compounds as anticancer agents
TW200505454A (en)	2005-02-16	Heteroaryl-fused pyrimidinyl compounds as anticancer agents
TW200503719A (en)	2005-02-01	Pyridino [1,2-a] pyrimidin-4-one compounds as anticancer agents
WO2004006859A3 (en)	2004-07-01	Platinum compound
TW200718689A (en)	2007-05-16	2-Amino-quinazolin-5-ones
TNSN08143A1 (en)	2009-07-14	2-amino-7,8-dihydro-6h-pyrido[4,3-d]pyrimidin-5-ones
BG108269A (en)	2004-12-30	Pyrazolopyrimidines as therapeutic agents
BG108268A (en)	2005-04-30	Pyrazolopyrimidines as therapeutic agents
PL377821A1 (pl)	2006-02-20	2,4,6-tripodstawione pirymidyny jako inhibitory kinazy fosfatydyloinozytolu (PI) 3 i ich zastosowanie w leczeniu nowotworu
SI1742644T1 (sl)	2012-03-30	Terapevtski sestavek ki vsebuje vsaj en derivat pirolobenzodiazepina in fludarabin
NO20062398L (no)	2006-07-27	Daglig, oral, kontrollert frigivnings oksycodon-doserings form
IL176110A0 (en)	2006-10-05	Azabicyclic heterocycles as cannabinoid receptor modulators
GEP20084551B (en)	2008-11-25	4-phenylamino-quinazolin-6-yl-amides
TW200631578A (en)	2006-09-16	Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury
WO2005004808A3 (en)	2005-03-17	TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS
TW200722083A (en)	2007-06-16	Combinations and methods of using an indolinone compound
WO2007062093A3 (en)	2008-10-23	Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
WO2004009609A3 (en)	2004-10-21	Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
TW200505443A (en)	2005-02-16	Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
TW200716091A (en)	2007-05-01	New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2021011289A (es)	2021-11-03	Composiciones que comprenden moduladores de isoenzima m2 muscular de piruvato cinasa pkm2 y metodos de tratamiento que usan las mismas.
WO2006102375A3 (en)	2009-04-02	Methods for avoiding edema in the treatment or prevention of pparϝ-responsive diseases, including cancer
MX2010004314A (es)	2010-04-30	Compuestos para inhibir la actividad de quinesina de la proteina quinesina del huso.
WO2006031719A3 (en)	2006-09-14	1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof